SC 13G/A: Teladoc Health, Inc.
Ticker: TDOC · Form: SC 13G/A · Filed: 2024-02-13T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Teladoc Health, Inc..
Risk Assessment
Risk Level: low
From the Filing
0001140361-24-007284.txt : 20240213 0001140361-24-007284.hdr.sgml : 20240213 20240213093949 ACCESSION NUMBER: 0001140361-24-007284 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89259 FILM NUMBER: 24622991 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Nikko Asset Management Americas, Inc. CENTRAL INDEX KEY: 0001480751 ORGANIZATION NAME: IRS NUMBER: 941302123 STATE OF INCORPORATION: DE FISCAL YEAR END: 0310 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 605 THIRD AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10158 BUSINESS PHONE: 212-610-6100 MAIL ADDRESS: STREET 1: 605 THIRD AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10158 SC 13G/A 1 ef20021432_sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Teladoc Health, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 87918A105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 1 NAMES OF REPORTING PERSONS     Nikko Asset Management Americas, Inc.         2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP     (a)☐     (b) ☐     3 SEC USE ONLY               4 CITIZENSHIP OR PLACE OF ORGANIZATION     USA         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER     0         6 SHARED VOTING POWER     4,941,273         7 SOLE DISPOSITIVE POWER     0         8 SHARED DISPOSITIVE POWER     7,464,874         9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     7,464,874         10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)     ☐         11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)     4.50%         12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)     IA         Item 1.   (a) Name of Issuer   Teladoc Health, Inc.         (b) Address of Issuer’s Principal Executive Offices   2 Manhatta